Compugen Ltd (CGEN)
1.41
-0.04
(-2.76%)
USD |
NASDAQ |
Nov 22, 16:00
1.405
0.00 (0.00%)
After-Hours: 20:00
Compugen Enterprise Value: 13.54M for Nov. 22, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 22, 2024 | 13.54M |
| November 21, 2024 | 17.12M |
| November 20, 2024 | 15.33M |
| November 19, 2024 | 16.23M |
| November 18, 2024 | 15.33M |
| November 15, 2024 | 13.54M |
| November 14, 2024 | 20.70M |
| November 13, 2024 | 29.66M |
| November 12, 2024 | 30.55M |
| November 11, 2024 | 43.09M |
| November 08, 2024 | 46.67M |
| November 07, 2024 | 49.35M |
| November 06, 2024 | 41.30M |
| November 05, 2024 | 34.13M |
| November 04, 2024 | 34.13M |
| November 01, 2024 | 40.40M |
| October 31, 2024 | 30.55M |
| October 30, 2024 | 34.13M |
| October 29, 2024 | 36.82M |
| October 28, 2024 | 38.61M |
| October 25, 2024 | 39.51M |
| October 24, 2024 | 41.30M |
| October 23, 2024 | 38.61M |
| October 22, 2024 | 37.72M |
| October 21, 2024 | 40.40M |
| Date | Value |
|---|---|
| October 18, 2024 | 40.40M |
| October 17, 2024 | 42.19M |
| October 16, 2024 | 39.51M |
| October 15, 2024 | 33.24M |
| October 14, 2024 | 37.72M |
| October 11, 2024 | 41.30M |
| October 10, 2024 | 41.30M |
| October 09, 2024 | 43.09M |
| October 08, 2024 | 42.19M |
| October 07, 2024 | 45.77M |
| October 04, 2024 | 51.15M |
| October 03, 2024 | 46.67M |
| October 02, 2024 | 60.10M |
| October 01, 2024 | 52.94M |
| September 30, 2024 | 49.35M |
| September 27, 2024 | 69.61M |
| September 26, 2024 | 64.68M |
| September 25, 2024 | 63.79M |
| September 24, 2024 | 65.58M |
| September 23, 2024 | 65.58M |
| September 20, 2024 | 71.85M |
| September 19, 2024 | 72.74M |
| September 18, 2024 | 78.12M |
| September 17, 2024 | 74.53M |
| September 16, 2024 | 79.91M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-38.55M
Minimum
Sep 29 2022
1.472B
Maximum
Aug 25 2020
329.86M
Average
140.28M
Median
Feb 08 2024
Enterprise Value Benchmarks
| Pluri Inc | 32.16M |
| BioLine Rx Ltd | 11.62M |
| XTL Biopharmaceuticals Ltd | 7.905M |
| Can Fite Biofarma Ltd | 7.221M |
| BiomX Inc | 5.009M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 1.276M |
| Revenue (Quarterly) | 17.13M |
| Total Expenses (Quarterly) | 12.64M |
| EPS Diluted (Quarterly) | 0.01 |
| Gross Profit Margin (Quarterly) | 78.98% |
| Profit Margin (Quarterly) | 7.45% |
| Earnings Yield | 2.13% |
| Operating Earnings Yield | 8.40% |
| Normalized Earnings Yield | 2.128 |